Stocks and Finance

Myriad Genetics

Myriad Genetics 8/24/2011

14:48 : Despite Gene Patent Victory, Myriad Genetics Faces Challenges - Myriad Genetics plans to rely less on patents and more on trade secrets #x2014; leveraging its huge database on gene mutations to defend its franchise in testing for breast cancer risk.
Source : nytimes-com

Myriad Genetics 7/20/2011

02:39 : Myriad Genetics: This Leading Developer of Diagnostic Products Is Catching - Myriad Genetics (MYGN), a leading developer of molecular diagnostic and therapeutic products, is predictably on track to expand its pipeline and broaden its markets in the U.S. and overseas.
Source : forbes-com

Myriad Genetics 3/22/2011

09:19 : Myriad Genetics Patent Appeal Case Arguments Begin April 4 - Oral arguments for the Myriad Genetics, Inc. (NASDAQ: MYGN) appeals case is set to begin April 4 with a possible written decision in June 2011, RBC Capital Markets said.
Source : ibtimes-com
actualidad Myriad Genetics -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts